Ende, Jonathan .

HRN: 22-12-35  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/31/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/31/2022
11/07/2022
IV
800 Mg
Q8
T/C Kawasaki R/O Strep Infection
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Eye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: Non-compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: